Cetuximab
Showing 1 - 25 of 1,156
Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab + Envafolimab + mFOLFOXIRI
- Cetuximab + mFOLFOX6/FOLFIRI
- (no location specified)
Jul 24, 2023
Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)
Not yet recruiting
- Locally Advanced Hypopharyngeal Carcinoma
- three cycles (toripalimab + cetuximab + platinum)
- +2 more
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 22, 2023
Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- Crisaborole Ointment
- Cetuximab
-
Guangzhou, Guangdong, ChinaWeiWei Xiao
Nov 3, 2023
Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Xevinapant
- +3 more
- (no location specified)
Jul 3, 2023
Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2023
Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)
Not yet recruiting
- Advanced Colorectal Cancer
- Cetuximab Dabrafenib Tislelizumab
-
Hangzhou, Zhejing, ChinaZhejiang Cancer Institute & Hospital
Jul 19, 2023
Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- +2 more
- BET Bromodomain Inhibitor ZEN-3694
- +6 more
- (no location specified)
Oct 25, 2023
Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab and irinotecan
- (no location specified)
Jul 26, 2023
Lung Cancer, Video-assisted Thoracic Surgery, EGFR Trial in Torino (Cetuximab-IRDye800)
Not yet recruiting
- Lung Cancer
- +3 more
-
Torino, TO, ItalyAzienda Ospedaliera Universitaria Città della Salute e della Sci
Oct 23, 2023
Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)
Not yet recruiting
- Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
- Cetuximab
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Oct 24, 2023
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,
Not yet recruiting
- Metastatic Head-and-neck Squamous-cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Ficlatuzumab
- +2 more
- (no location specified)
Sep 26, 2023
Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- mFOLFOX6 + Cetuximab
- mFOLFOX 6
-
Shanghai, ChinaZhongshan hosptial, Fudan University
Jul 14, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023
Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)
Recruiting
- Glioblastoma
- High-grade Glioma
-
Groningen, NetherlandsUMCG
Jun 26, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
Colorectal Cancer Liver Metastases Trial in Shanghai (Cetuximab)
Not yet recruiting
- Colorectal Cancer Liver Metastases
- Cetuximab
-
Shanghai, Shanghai, China
- +1 more
May 22, 2023
Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)
Not yet recruiting
- Head Neck
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2023
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Neoadjuvant Therapy
- 3cycles (Toripalimab + cetuximab)
- +2 more
-
Wuhan, Hebei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)
Not yet recruiting
- Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
- HMBD-001
- +2 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 20, 2023
Advance NSCLC Trial (GFH925, Cetuximab)
Not yet recruiting
- Advance Non-small Cell Lung Cancer
- GFH925
- Cetuximab
- (no location specified)
Mar 7, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- Capecitabine
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)
Not yet recruiting
- Colorectal Cancer
- Non-Small Cell Lung Cancer
- GDC-1971
- +2 more
- (no location specified)
Jul 12, 2023
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)
Recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- Cetuximab
- Imatinib
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Apr 24, 2023
Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,
Not yet recruiting
- Colon Adenocarcinoma
- +4 more
- Encorafenib
- +5 more
- (no location specified)
Jan 24, 2023